Literature DB >> 25680668

Food components and irritable bowel syndrome.

Peter R Gibson1, Jane Varney2, Sreepurna Malakar2, Jane G Muir2.   

Abstract

Ingestion of food has long been linked with gut symptoms, and there is increasing interest in using diet in the management of patients with irritable bowel syndrome (IBS). The West has developed an intense interest in specialized, restrictive diets, such as those that target multiple food groups, avoid gluten, or reduce fermentable oligo-, di-, and mono-saccharides and polyols. However, most gastroenterologists are not well educated about diets or their effects on the gut. It is important to understand the various dietary approaches, their putative mechanisms, the evidence that supports their use, and the benefits or harm they might produce. The concepts behind, and delivery of, specialized diets differ from those of pharmacologic agents. High-quality research is needed to determine the efficacy of different dietary approaches and the place of specific strategies.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bioactive Food Chemicals; Carbohydrates; Dietary Therapy; Functional Gastrointestinal Disorders; Gluten; Low FODMAP Diet; Proteins; Wheat Sensitivity

Mesh:

Substances:

Year:  2015        PMID: 25680668     DOI: 10.1053/j.gastro.2015.02.005

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  41 in total

1.  Gastrointestinal symptoms predictors of health-related quality of life in pediatric patients with functional gastrointestinal disorders.

Authors:  James W Varni; Robert J Shulman; Mariella M Self; Samuel Nurko; Miguel Saps; Shehzad A Saeed; Ashish S Patel; Chelsea Vaughan Dark; Cristiane B Bendo; John F Pohl
Journal:  Qual Life Res       Date:  2016-10-14       Impact factor: 4.147

Review 2.  Food: The Main Course to Wellness and Illness in Patients With Irritable Bowel Syndrome.

Authors:  William D Chey
Journal:  Am J Gastroenterol       Date:  2016-02-09       Impact factor: 10.864

Review 3.  New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists.

Authors:  Amy E Foxx-Orenstein
Journal:  Therap Adv Gastroenterol       Date:  2016-02-21       Impact factor: 4.409

4.  Health Benefits and Adverse Effects of a Gluten-Free Diet in Non-Celiac Disease Patients.

Authors:  Benjamin Niland; Brooks D Cash
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-02

Review 5.  Eosinophilic esophagitis: What can we learn from Crohn's disease?

Authors:  Javier Molina-Infante; Alain M Schoepfer; Alfredo J Lucendo; Evan S Dellon
Journal:  United European Gastroenterol J       Date:  2016-09-29       Impact factor: 4.623

6.  Dietary interventions for induction and maintenance of remission in inflammatory bowel disease.

Authors:  Berkeley N Limketkai; Zipporah Iheozor-Ejiofor; Teuta Gjuladin-Hellon; Alyssa Parian; Laura E Matarese; Kelly Bracewell; John K MacDonald; Morris Gordon; Gerard E Mullin
Journal:  Cochrane Database Syst Rev       Date:  2019-02-08

7.  Genetics of irritable bowel syndrome.

Authors:  Maria Henström; Mauro D'Amato
Journal:  Mol Cell Pediatr       Date:  2016-02-12

Review 8.  Selective Manipulation of the Gut Microbiota Improves Immune Status in Vertebrates.

Authors:  Ana Montalban-Arques; Peter De Schryver; Peter Bossier; Gregor Gorkiewicz; Victoriano Mulero; Delbert Monroe Gatlin; Jorge Galindo-Villegas
Journal:  Front Immunol       Date:  2015-10-09       Impact factor: 7.561

9.  Fructose Malabsorption in Systemic Sclerosis.

Authors:  Isabelle Marie; Anne-Marie Leroi; Guillaume Gourcerol; Hervé Levesque; Jean-François Ménard; Philippe Ducrotte
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

Review 10.  Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome.

Authors:  Duo-Chen Jin; Hai-Long Cao; Meng-Que Xu; Si-Nan Wang; Yu-Ming Wang; Fang Yan; Bang-Mao Wang
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.